Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Synopsys (SNPS) Beats Q1 Earnings and Revenue Estimates
Synopsys (SNPS) Beats Q1 Earnings and Revenue Estimates

Synopsys (SNPS) came out with quarterly earnings of $3.77 per share, beating the Zacks Consensus Estimate of $3.57 per share. This compares to earnings of $3.03 per share a year ago. These figures

Snowflake Inc. (SNOW) Tops Q4 Earnings and Revenue Estimates
Snowflake Inc. (SNOW) Tops Q4 Earnings and Revenue Estimates

Snowflake Inc. (SNOW) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.3 per share a year ago. These

Nutanix (NTNX) Q2 Earnings and Revenues Surpass Estimates
Nutanix (NTNX) Q2 Earnings and Revenues Surpass Estimates

Nutanix (NTNX) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.56 per share a year ago. These figures

Pure Storage (PSTG) Q4 Earnings and Revenues Beat Estimates
Pure Storage (PSTG) Q4 Earnings and Revenues Beat Estimates

Pure Storage (PSTG) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.45 per share a year ago. These

PROCEPT BioRobotics Corporation (PRCT) Reports Q4 Loss, Lags Revenue Estimates
PROCEPT BioRobotics Corporation (PRCT) Reports Q4 Loss, Lags Revenue Estimates

PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to a loss of $0.35 per share a year

Permian Resources (PR) Tops Q4 Earnings Estimates
Permian Resources (PR) Tops Q4 Earnings Estimates

Permian Resources (PR) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.36 per share a year ago. These

RxSight, Inc. (RXST) Reports Q4 Loss, Beats Revenue Estimates
RxSight, Inc. (RXST) Reports Q4 Loss, Beats Revenue Estimates

RxSight, Inc. (RXST) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to earnings of $0.03 per share a year ago. These figures

IonQ, Inc. (IONQ) Surpasses Q4 Earnings and Revenue Estimates
IonQ, Inc. (IONQ) Surpasses Q4 Earnings and Revenue Estimates

IonQ, Inc. (IONQ) came out with quarterly earnings of $1.93 per share, beating the Zacks Consensus Estimate of a loss of $0.48 per share. This compares to a loss of $0.93 per share a year ago. These

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates
Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates

Mirum Pharmaceuticals, Inc. (MIRM) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of $0.02. This compares to a loss of $0.49 per share a year ago. These

McGrath (MGRC) Q4 Earnings and Revenues Top Estimates
McGrath (MGRC) Q4 Earnings and Revenues Top Estimates

McGrath (MGRC) came out with quarterly earnings of $2.02 per share, beating the Zacks Consensus Estimate of $1.74 per share. This compares to earnings of $1.58 per share a year ago. These figures

Montrose Environmental (MEG) Beats Q4 Earnings and Revenue Estimates
Montrose Environmental (MEG) Beats Q4 Earnings and Revenue Estimates

Montrose Environmental (MEG) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.29 per share a year ago

MiMedx (MDXG) Q4 Earnings and Revenues Beat Estimates
MiMedx (MDXG) Q4 Earnings and Revenues Beat Estimates

MiMedx (MDXG) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.07 per share a year ago. These figures are

Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q4 Loss, Beats Revenue Estimates
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q4 Loss, Beats Revenue Estimates

Maravai LifeSciences Holdings, Inc. (MRVI) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.06 per share a year

Chord Energy Corporation (CHRD) Q4 Earnings Top Estimates
Chord Energy Corporation (CHRD) Q4 Earnings Top Estimates

Chord Energy Corporation (CHRD) came out with quarterly earnings of $1.28 per share, beating the Zacks Consensus Estimate of $1.17 per share. This compares to earnings of $3.49 per share a year ago

Salesforce (CRM) Beats Q4 Earnings and Revenue Estimates
Salesforce (CRM) Beats Q4 Earnings and Revenue Estimates

Salesforce (CRM) came out with quarterly earnings of $3.81 per share, beating the Zacks Consensus Estimate of $3.03 per share. This compares to earnings of $2.78 per share a year ago. These figures

BJ's Restaurants (BJRI) Q4 Earnings and Revenues Surpass Estimates
BJ's Restaurants (BJRI) Q4 Earnings and Revenues Surpass Estimates

BJ's Restaurants (BJRI) came out with quarterly earnings of $0.66 per share, beating the Zacks Consensus Estimate of $0.6 per share. This compares to earnings of $0.47 per share a year ago. These

Churchill Downs (CHDN) Q4 Earnings and Revenues Beat Estimates
Churchill Downs (CHDN) Q4 Earnings and Revenues Beat Estimates

Churchill Downs (CHDN) came out with quarterly earnings of $0.97 per share, beating the Zacks Consensus Estimate of $0.85 per share. This compares to earnings of $0.92 per share a year ago. These

Enovix Corporation (ENVX) Reports Q4 Loss, Beats Revenue Estimates
Enovix Corporation (ENVX) Reports Q4 Loss, Beats Revenue Estimates

Enovix Corporation (ENVX) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.11 per share a year ago. These

ARKO Corp. (ARKO) Reports Break-Even Earnings for Q4
ARKO Corp. (ARKO) Reports Break-Even Earnings for Q4

ARKO Corp. (ARKO) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.03 per share a year ago. These figures are

Amerisafe (AMSF) Q4 Earnings Miss Estimates
Amerisafe (AMSF) Q4 Earnings Miss Estimates

Amerisafe (AMSF) came out with quarterly earnings of $0.51 per share, missing the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.67 per share a year ago. These figures

Acadia Pharmaceuticals (ACAD) Q4 Earnings Top Estimates
Acadia Pharmaceuticals (ACAD) Q4 Earnings Top Estimates

Acadia Pharmaceuticals (ACAD) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.17 per share a year ago

Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates
Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates

Arcutis Biotherapeutics, Inc. (ARQT) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to a loss of $0.09 per share a year

Alector (ALEC) Reports Q4 Loss, Beats Revenue Estimates
Alector (ALEC) Reports Q4 Loss, Beats Revenue Estimates

Alector (ALEC) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to a loss of $0.02 per share a year ago. These figures are

Agilent Technologies (A) Lags Q1 Earnings and Revenue Estimates
Agilent Technologies (A) Lags Q1 Earnings and Revenue Estimates

Agilent Technologies (A) came out with quarterly earnings of $1.36 per share, missing the Zacks Consensus Estimate of $1.37 per share. This compares to earnings of $1.31 per share a year ago. These

Brian's Big Idea - No Zacks Rank But On My Radar
Brian's Big Idea - No Zacks Rank But On My Radar

We get a lot of emails from people that want to understand why some stocks have a Zacks Rank and why some do not.  The answer is really quite simple, there needs to be equity research submitted to